Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination

Annals of Surgical Oncology

Volumn 18, Issue 13, 2011, Pages 3726-3731

  Fujiwara, Yoshiyuki ^a   Takiguchi, Shuji ^a   Nakajima, Kiyokazu ^a   Miyata, Hiroshi ^a   Yamasaki, Makoto ^a   Kurokawa, Yukinori ^a   Okada, Kaoru ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; FATIGUE; FEMALE; GASTRECTOMY; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PERITONEUM METASTASIS; SIDE EFFECT; STOMACH CANCER; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TAXOIDS;

EID: 82955249264     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1770-8     Document Type: Article

References (30)

1. JB Dupont JR Lee GR Burton, et al. 1978 Adenocarcinoma of the stomach: review of 1497 cases Cancer. 41 941 947 638980 10.1002/1097-0142(197803)41: 3<941::AID-CNCR2820410323>3.0.CO;2-M (Pubitemid 8313231)
2. E Yamada S Miyaishi H Nakazato, et al. 1980 The surgical treatment of cancer of the stomach Int Surg. 65 387 399 6161095 1:STN:280: DyaL3M%2FptlWkug%3D%3D (Pubitemid 12115232)
3. E Bando Y Yonemura Y Takeshita, et al. 1999 Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma Am J Surg. 178 256 262 10527450 10.1016/S0002-9610(99)00162-2 1:STN:280:DyaK1MvlsVGktg%3D%3D (Pubitemid 29475109)
4. M Benevolo 1998 Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer J Clin Oncol. 16 3406 3411 9779720 1:STN:280:DyaK1cvltFSjsg%3D%3D (Pubitemid 28481640)
5. S Koga N Kaibara Y Iitsuka, et al. 1984 Prognostic significance of intra-peritoneal free cancer cells in gastric cancer patients J Cancer Res Clin Oncol. 108 236 238 6470030 10.1007/BF00402474 1:STN:280:DyaL2c3ovFKmsw%3D%3D (Pubitemid 14057507)
6. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann DG Haller JA Ajani LL Gunderson JM Jessup JA Martenson 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma o the stomach or gastroesophageal junction N Engl J Med. 345 725 730 11547741 10.1056/NEJMoa010187 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D
7. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ; MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
8. JA Ajani J Fairweather P Dumas YZ Patt R Pazdur PF Mansfield 1988 Phase II study of Taxol in patients with advanced gastric carcinoma Cancer J Sci Am. 4 269 274
9. AI Einzig D Neuberg SC Remick DD Karp PJ O'Dwyer JA Stewart AB Benson 3rd 1996 Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293 Med Oncol. 13 87 93 9013471 10.1007/BF02993858 1:STN:280: DyaK2s7msFOisg%3D%3D (Pubitemid 27019943)
10. Futatsuki K, Wakui A, Nakao I, Sakata Y, Kambe M, Shimada Y, Yoshino M, Taguchi T, Ogawa N. Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group. Jpn J Cancer Chemother. 1994;21:1033-8. (Pubitemid 24225031)
11. T Taguchi S Tsukagoshi H Furue H Niitani K Noda 1998 Phase I clinical study of oxaliplatin Jpn J Cancer Chemother. 25 1899 1907 1:STN:280: DyaK1M%2FhsVGntA%3D%3D
12. Y Sakata A Ohtsu N Horikoshi K Sugimachi Y Mitachi T Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M Gimestat-1 M Ovastat potassium) in advanced gastric cancer patients Eur J Cancer. 34 1715 1720 9893658 10.1016/S0959-8049(98)00211-1 1:CAS:528:DyaK1cXntlShurw%3D (Pubitemid 28474225)
13. C Liu Q Sun X Hang B Zhong D Wang 2008 Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer Anticancer Drugs. 19 825 831 18690095 10.1097/CAD.0b013e32830c457e 1:CAS:528:DC%2BD1cXpsFKqu78%3D
14. T Makino Y Fujiwara S Takiguchi H Miyata M Yamasaki K Nakajima T Nishida M Mori Y Doki 2010 The utility of preoperative peritoneal lavage examination in serosa-invading gastric cancer patients Surgery. 148 96 102 20096433 10.1016/j.surg.2009.11.025
15. M Yano T Yasuda Y Fujiwara S Takiguchi H Miyata M Monden 2004 Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer J Surg Oncol. 88 39 43 15384086 10.1002/jso.20133 (Pubitemid 39313819)
16. K Yamamoto Y Fujiwara T Nishida S Takiguchi K Nakajima H Miyata M Yamasaki M Mori Y Doki 2009 Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer Anticancer Res. 2 4211 4215
17. E Van Cutsem VM Moiseyenko S Tjulandin A Majlis M Constenla C Boni A Rodrigues M Fodor Y Chao E Voznyi ML Risse JA Ajani 2006 V325 Study Group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol. 24 4991 4997 17075117 10.1200/JCO.2006.06. 8429 (Pubitemid 46631401)
18. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors J Nat Cancer Inst. 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D (Pubitemid 30099779)
19. Yoshikawa T, Sasako M, Yamamoto S, Sano T, Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y, Fukushima N. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg. 2009;96:1015-22.
20. Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16:3227-36.
21. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810-20. (Pubitemid 350044801)
22. C Schuhmacher S Gretschel F Lordick P Reichardt W Hohenberger CF Eisenberger C Haag ME Mauer B Hasan J Welch K Ott A Hoelscher PM Schneider W Bechstein H Wilke MP Lutz B Nordlinger EV Cutsem JR Siewert PM Schlag 2010 Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954 J Clin Oncol. 28 5210 5218 21060024 10.1200/JCO.2009.26.6114
23. Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol. 2010;16:5621-8.
24. B Badgwell JN Cormier S Krishnan J Yao GA Staerkel PJ Lupo PW Pisters B Feig P Mansfield 2008 Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol. 15 2684 2691 18649106 10.1245/s10434-008-0055-3
25. S Lorenzen B Panzram R Rosenberg H Nekarda K Becker U Schenk H Höfler JR Siewert D Jäger K Ott 2010 Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection Ann Surg Oncol. 17 2733 2739 20490698 10.1245/s10434-010-1090-4
26. W Koizumi H Narahara T Hara A Takagane T Akiya M Takagi K Miyashita T Nishizaki O Kobayashi W Takiyama Y Toh T Nagaie S Takagi Y Yamamura K Yanaoka H Orita M Takeuchi 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol. 9 215 221 18282805 10.1016/S1470-2045(08)70035-4 1:CAS:528: DC%2BD1cXivVaqtb4%3D
27. M Markman BN Bundy DS Alberts JM Fowler DL Clark-Pearson LF Carson S Wadler J Sickel 2001 Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol. 19 1001 1007 11181662 1:CAS:528:DC%2BD3MXhvFersbg%3D (Pubitemid 32176274)
28. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA; Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34-43. (Pubitemid 43048949)
29. H Ishigami J Kitayama S Kaisaki A Hidemura M Kato K Otani T Kamei D Soma H Miyato H Yamashita H Nagawa 2010 Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis Ann Oncol. 21 67 70 19605503 10.1093/annonc/mdp260 1:STN:280:DC%2BD1Mfisl2isQ%3D%3D
30. Y Fujiwara T Nishida S Takiguchi K Nakajima H Miyata M Yamasaki K Yamamoto JH Moon M Mori Y Doki 2010 Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination Anticancer Res. 30 1335 1339 20530449 1:CAS:528: DC%2BC3cXovV2gtrk%3D